Filing Details

Accession Number:
0001596783-18-000023
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-12 11:44:38
Reporting Period:
2018-03-08
Accepted Time:
2018-03-12 11:44:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1596783 Catalent Inc. CTLT Pharmaceutical Preparations (2834) 208737688
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1612228 William Downie C/O Catalent, Inc.
14 Schoolhouse Road
Somerset NJ 08873
Svp, Global Sales & Marketing No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-03-08 5,061 $20.50 46,986 No 4 M Direct
Common Stock Disposition 2018-03-08 3,914 $40.95 43,072 No 4 F Direct
Common Stock Acquisiton 2018-03-08 6,116 $31.96 49,188 No 4 M Direct
Common Stock Disposition 2018-03-08 5,507 $40.95 43,681 No 4 F Direct
Common Stock Acquisiton 2018-03-08 4,338 $24.44 48,019 No 4 M Direct
Common Stock Disposition 2018-03-08 3,544 $40.95 44,475 No 4 F Direct
Common Stock Disposition 2018-03-08 9,082 $41.80 35,393 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options to purchase Common Stock Disposition 2018-03-08 5,061 $0.00 5,061 $20.50
Common Stock Options to purchase Common Stock Disposition 2018-03-08 6,116 $0.00 6,116 $31.96
Common Stock Options to purchase Common Stock Disposition 2018-03-08 4,338 $0.00 4,338 $24.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,061 2015-07-30 2024-07-30 No 4 M Direct
6,117 2016-08-27 2025-08-27 No 4 M Direct
13,015 2017-07-26 2026-07-26 No 4 M Direct
Footnotes
  1. On July 30, 2014, the reporting person was granted options to purchase common stock of the Issuer, which options vest and become exercisable in four equal annual installments beginning on July 30, 2015. (S1221)
  2. On August 27, 2015, the reporting person was granted options to purchase common stock of the Issuer, which options vest and become exercisable in four equal annual installments beginning on August 27, 2016. (S10)
  3. On July 26, 2016, the reporting person was granted options to purchase common stock of the Issuer, which options vest and become exercisable in four equal annual installments beginning on July 26, 2017. (S68)